These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22706847)

  • 1. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.
    Ito K; Stannard K; Gabutero E; Clark AM; Neo SY; Onturk S; Blanchard H; Ralph SJ
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):763-78. PubMed ID: 22706847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling galectin-1 as a novel therapeutic target for cancer.
    Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
    Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
    Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
    Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease.
    Dalotto-Moreno T; Croci DO; Cerliani JP; Martinez-Allo VC; Dergan-Dylon S; Méndez-Huergo SP; Stupirski JC; Mazal D; Osinaga E; Toscano MA; Sundblad V; Rabinovich GA; Salatino M
    Cancer Res; 2013 Feb; 73(3):1107-17. PubMed ID: 23204230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1: a link between tumor hypoxia and tumor immune privilege.
    Le QT; Shi G; Cao H; Nelson DW; Wang Y; Chen EY; Zhao S; Kong C; Richardson D; O'Byrne KJ; Giaccia AJ; Koong AC
    J Clin Oncol; 2005 Dec; 23(35):8932-41. PubMed ID: 16219933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of galectin-3 in cancer apoptosis.
    Nakahara S; Oka N; Raz A
    Apoptosis; 2005 Mar; 10(2):267-75. PubMed ID: 15843888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells.
    Zhao XY; Chen TT; Xia L; Guo M; Xu Y; Yue F; Jiang Y; Chen GQ; Zhao KW
    Carcinogenesis; 2010 Aug; 31(8):1367-75. PubMed ID: 20525878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
    Ito K; Scott SA; Cutler S; Dong LF; Neuzil J; Blanchard H; Ralph SJ
    Angiogenesis; 2011 Sep; 14(3):293-307. PubMed ID: 21523436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.
    Salatino M; Croci DO; Laderach DJ; Compagno D; Gentilini L; Dalotto-Moreno T; Dergan-Dylon LS; Méndez-Huergo SP; Toscano MA; Cerliani JP; Rabinovich GA
    Methods Mol Biol; 2015; 1207():293-304. PubMed ID: 25253148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3--a jack-of-all-trades in cancer.
    Newlaczyl AU; Yu LG
    Cancer Lett; 2011 Dec; 313(2):123-8. PubMed ID: 21974805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
    Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
    Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.
    Stannard KA; Collins PM; Ito K; Sullivan EM; Scott SA; Gabutero E; Darren Grice I; Low P; Nilsson UJ; Leffler H; Blanchard H; Ralph SJ
    Cancer Lett; 2010 Dec; 299(2):95-110. PubMed ID: 20826047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin 3 as a guardian of the tumor microenvironment.
    Ruvolo PP
    Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
    Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
    Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
    Brahimi-Horn C; Pouysségur J
    Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectins in the Tumor Microenvironment: Focus on Galectin-1.
    Martínez-Bosch N; Navarro P
    Adv Exp Med Biol; 2020; 1259():17-38. PubMed ID: 32578169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma.
    Suzuki O; Nozawa Y; Abe M
    Oncol Rep; 2005 Jan; 13(1):109-14. PubMed ID: 15583810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.
    Iurisci I; Cumashi A; Sherman AA; Tsvetkov YE; Tinari N; Piccolo E; D'Egidio M; Adamo V; Natoli C; Rabinovich GA; Iacobelli S; Nifantiev NE;
    Anticancer Res; 2009 Jan; 29(1):403-10. PubMed ID: 19331179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.